Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder

Medicine and Dentistry

• Neoplasm 100%
• Transitional Cell Carcinoma 100%
• Bladder 100%
• Protein Expression 60%
• Urothelium 60%
• Transcription Factor EZH2 60%
• Bladder Cancer Cell Line 60%
• Cancer 40%
• Reverse Transcription Polymerase Chain Reaction 40%
• Bladder Tumor 40%
• Cell Line 20%
• Carcinogenesis 20%
• Immunohistochemistry 20%
• Gene Silencing 20%
• Bladder Cancer 20%
• Repressor Gene 20%
• Bladder Tissue 20%

Keyphrases

• Enhancer of Zeste Homolog 2 (EZH2) 100%
• Bladder Transitional Cell Carcinoma 100%
• MRNA Expression 38%
• Bladder 22%
• Protein Expression 16%
• Quantitative PCR 11%
• Nontumor 11%
• Invasive Tumors 11%
• Bladder Tumor 11%
• Superficial Tumor 11%
• Breast 5%
• Prostate 5%
• Protein Level 5%
• Gene Silencing 5%
• Tissue Specimens 5%
• Immunohistochemistry 5%
• Bladder Cancer 5%
• Transcriptional Repressor 5%
• Malignancy 5%
• Human Malignancies 5%
• Oncogenesis 5%
• Lymphoma 5%
• Neoplastic Tissue 5%
• Low-grade Lesions 5%
• High-grade Tumor 5%
• Low-grade Tumor 5%
• Urothelium 5%